In conclusion, our study provides novel evidence that FSHR polymorphisms at rs6165 (position 307) and rs6166 (position 680) are associated with ovarian response in women with PCOS undergoing ovulation induction with letrozole. The gene discussed is FSHR; the disease is polycystic ovary syndrome.